Intrinsic Value of S&P & Nasdaq Contact Us

GRAIL, Inc. GRAL NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
56/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$88.00
+74.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

GRAIL, Inc. (GRAL) has a negative trailing P/E of -4.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -20.46%.

Criteria proven by this page:

  • VALUE (62/100, Pass) — analyst target implies upside (+74.3%).
  • Trailing Earnings Yield -20.46% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $88.00 (+74.3% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 56/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
56/100
SG Score
View full scorecard →
VALUE
62/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — GRAL

Valuation Multiples
P/E (TTM)-4.9
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.77
P/S Ratio13.66
EV/EBITDA-5.0
Per Share Data
EPS (TTM)$-10.03
Book Value / Share$63.30
Revenue / Share$3.61
FCF / Share$-7.34
Yields & Fair Value
Earnings Yield-20.46%
Dividend Yield0.00%
Analyst Target$88.00 (+74.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -5.7 0.00 2.60 0.00 -
2019 -6.9 0.39 3.06 0.00 -
2020 -5.4 -0.20 3.01 0.00 -
2021 -0.3 0.00 0.04 29.03 -
2022 -0.1 0.00 0.09 7.64 -
2023 -0.3 0.00 0.12 4.56 -
2024 -0.3 -0.01 0.23 4.53 -
2025 -7.7 0.09 1.22 21.37 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-2.42 $0.00 $-275.72M -
2019 $-1.99 $0.00 $-244.86M -
2020 $-2.52 $0.00 $-312.16M -
2021 $-40.18 $14.61M $-1.25B -8539.4%
2022 $-173.87 $55.55M $-5.4B -9719.3%
2023 $-47.20 $93.11M $-1.47B -1574.2%
2024 $-63.54 $125.6M $-2.03B -1613.9%
2025 $-11.11 $147.17M $-408.35M -277.5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-11.02 $-11.27 – $-10.76 $180.23M $171.98M – $185.71M 3
2027 $-10.79 $-11.39 – $-10.20 $219.35M $209.3M – $226.01M 3
2028 $-10.41 $-12.73 – $-9.26 $272.51M $272.51M – $272.51M 5
2029 $-9.74 $-10.12 – $-9.16 $367.13M $350.31M – $378.27M 1
2030 $-8.98 $-9.33 – $-8.44 $475.78M $453.99M – $490.22M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message